Quiver Bioscience
Quiver Bioscience develops therapeutics that translate human neuronal biology into new treatments for brain disorders. The company combines patient-derived stem-cell disease models, advanced single-cell imaging, multi-omics, and a proprietary “Genomic Positioning System” with AI/ML to identify targets and nominate candidate molecules. Its platform supports modalities including antisense oligonucleotides (ASO) and optogenetics and advances programs from target discovery through preclinical and clinical development. Quiver operates as a technology-driven B2B therapeutics developer that partners with pharmaceutical companies and researchers to de-risk neuroscience programs. Active pipelines include programs for chronic pain (Nav1.7, Nav1.8) and several seizure and neurodevelopmental disorders.
Quiver Bioscience
Quiver Bioscience develops therapeutics that translate human neuronal biology into new treatments for brain disorders. The company combines patient-derived stem-cell disease models, advanced single-cell imaging, multi-omics, and a proprietary “Genomic Positioning System” with AI/ML to identify targets and nominate candidate molecules. Its platform supports modalities including antisense oligonucleotides (ASO) and optogenetics and advances programs from target discovery through preclinical and clinical development. Quiver operates as a technology-driven B2B therapeutics developer that partners with pharmaceutical companies and researchers to de-risk neuroscience programs. Active pipelines include programs for chronic pain (Nav1.7, Nav1.8) and several seizure and neurodevelopmental disorders.
